Comparison of curcumin’s effects in simple and modified formulations in patients with metabolic syndrome

Phase 2

• Conditions: Non-insulin-dependent diabetes mellitus; Condition 1: Obesity. Condition 2: Non-insulin-dependent diabetes mellitus. Condition 3: hypertriglyceridaemia. Condition 4: hypertension. Condition 5: High-density lipoprotein deficiency.; Obesity; Pure hyperglyceridaemia; Essential (primary) hypertension; Lipoprotein deficiency

• Registration Number: IRCT2014052014521N3
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Inclusion criteria : Men and women aged 18-65 years ; Metabolic Syndrome patients (based on IDF guidelines) ; Consent to participate in research project ; Not taking any dietary supplement ; Not taking any drugs within the last 3-6 months (Not history of taking any lipid-lowering, diabetes and hypertension drugs or insulin within the last 3-6 months) .

Exclusion criteria : Lack of informed consent of patient to participate in research project ; Having systemic disease or history of systemic disease (such as lupus and kidney disease) ; Not having Metabolic Syndrome ; Pregnancy or lactation ; Consumption of any drug supplement or lipid-lowering drug within the last 3-6 months ; Metabolic syndrome subjects who need to take any drug (based on American Heart Association guidelines) .

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Triglycerides. Timepoint: Baseline, week 6. Method of measurement: Routine enzymatic methods using standard biochemistry kits on an autonalyzer.